SUMMARY Several blood-pressure-regulating factors including exchangeable sodium, blood volume, plasma renin, aldosterone, norepinephrine (NE), and epinephrine (E) levels, urinary catecholamine excretion rates, and Cardiovascular responsiveness to infused NE and angiotensin II (All) were compared among age-matched subgroups of normal subjects (15 with normal weight, 15 with overweight) and patients with essential hypertension (15 with either normal weight, overweight, or obesity). Exchangeable sodium, blood volume, plasma and urinary sodium and potassium, plasma renin, aldosterone and epinephrine levels, and NE or E excretion rates did not differ significantly among the five subgroups. Minimal differences included a slightly higher heart rate in overweight patients than in overweight normal subjects (p < 0.01) and a tendency for a higher plasma NE in overweight than in normal weight patients. Plasma NE obtained immediately before NE infusion as well as the plasma clearance of NE did not differ among the five subgroups except, however, for a somewhat low NE clearance in obese patients. The NE pressor dose tended to be lower in normalweight hypertensive than in normal-weight normotensive subjects. No alteration was apparent in overweight or obese hypertensive patients. Pressor responses to AH were similar in the different subgroups. These findings suggest that overweight does not confer a unique aberration in the body sodium-volume state, circulating renin, aldosterone or catecholamines, or cardiovascular responses to NE or AH which result in hypertension. (Hypertension 4:697-702, 1982) KEY WORDS • obesity • hypertension • body sodium • renin • aldosterone • norepinephrine • epinephrine * pressor response H IGH blood pressure and overweight are frequently associated, and both are considered as risk factors for cardiovascular morbidity.
H IGH blood pressure and overweight are frequently associated, and both are considered as risk factors for cardiovascular morbidity.
1 -: Possible pathogenetic links relating obesity to hypertension are still poorly understood. Several mechanisms have been considered. Overeating is usually accompanied by high salt intake and the latter factor per se may have a modulatory effect on blood pressure. 3 However, weight reduction with concomitant liberal salt intake may nevertheless lead to a fall in blood pressure. 45 Increased plasma insulin levels in the obese subjects could promote a renal sodium reabsorption 6 and, perhaps, also stimulate the sympathetic nervous system at central sites. 7 An increase in total blood volume 89 and high cardiac output in the presence of normal peripheral vascular resistance were reported in obese hypertensive subjects. 9 It has been suggested that hypervolemia could elicit tissue autoregulation, resulting in increased peripheral vascular resistance. 10 However, other investigators could not find different hemodynamic or volume characteristics between obese and nonobese hypertensive patients when cardiac output and blood volume were corrected to body surface area." Only limited data are available on renin, 5 9 aldosterone, 5 l2 and catecholamine activity; 7 ' 2 u increased activity of the adrenocortical gland in untreated obesity 14 and reduction in plasma renin activity and aldosterone after weight loss 5 have been reported in obesity.
The body sodium-volume state, the activity of the adrenergic system, and the function of the renin-angiotensin-aldosterone system are closely interrelated. 15 Moreover, even simultaneous measurements of the components may allow only limited insight into the overall blood pressure control, since the pressor effect of any vasoactive factor depends not only on its concentration but also may be modulated by alterations in vascular responsiveness. 15 -' 6 The present study was undertaken to evaluate interrelations among blood pressure and exchangeable body sodium, blood volume, plasma norepinephrine, epinephrine, renin and aldosterone levels, as well as cardiovascular pressor reponsiveness to norepinephrine or angiotensin II in lean and obese patients with essential hypertension as compared to normal subjects.
Subjects and Methods
Since 1974, we have prospectively investigated in our laboratory the role of several blood-pressure-regulating factors in the pathogenesis of essential hypertension. The aims of the investigations have included an evaluation of the influence of overweight on important parameters of blood pressure regulation. We have therefore invited any normal or eligible hypertensive subject with lean, overweight, or obese body size, who was willing to undergo the series of tests required (see below), to participate. As expected, an agreement to take part in the study was much easier to obtain from hypertensive patients than from the healthy subjects needed to form a control group. Recruitment of normotensive subjects with distinct obesity proved to be most difficult; of those available only two could be motivated to undergo the study procedure, which provided no benefit for their general health.
After a duration of 7 years, a further prolongation of this study did not appear to be justified. When it was concluded in early 1981, 99 normal subjects and 116 patients with mild-to-moderate essential hypertension had undergone the testing. These two populations whose clinical features were described in part previously 17 
"
20 provided the basis for the present analysis. The healthy volunteers had a blood pressure consistently below 140/90 mm Hg at three consecutive readings under outpatient conditions. No patient had malignant hypertension (hypertensive retinopathy Keith-Wagener III or IV), heart failure, coronary heart disease, stroke or transient ischemic attacks, or a plasma creatinine above 1.4 mg/dl. All subjects were in caloric balance at the time of the study. All subjects were instructed to continue to ingest their usual diet, but without very salty food or adding salt to their food, starting at least 5 days prior to the study. With this dietary instruction, 24-hour urinary excretion averaged 133 ± 6 mmoles in our control population and 155 ± 6 mmoles in the hypertensive population (table 1) . Information on the constancy of the sodium intake following such instruction was derived from repeated determination of sodium excretion. Mean coefficient of intraindividual variation of 24-hour sodium excretion in 59 subjects, studied twice with a mean interval of 40 ± 4 days, averaged 30% ± 3 % .
Following the oral administration of approximately 60 /LtCi of 24 Na between 8.00 and 8.30 a.m., a 24-hour urine sample was collected for the determination of 21 Na, 24 Na, potassium, creatinine, norepinephrine (NE), and epinephrine (E) excretion rates. At the end of the collection period, blood pressure, pulse rate, plasma sodium, potassium, creatinine, renin activity (PRA), aldosterone, plasma NE and E levels, exchangeable body sodium and blood volume were measured between 8.00 and 9.00 a.m. after 1 hour of recumbency; and blood pressure, pulse rate, plasma NE, E, renin, and aldosterone levels were again determined following 60 minutes of ambulation, according to our standard procedure. 1718 Intravenous cannulas were inserted at least 30 minutes before initial blood sampling. In addition, pressor responsiveness to NE and angiotensin II (All) was assessed according to the following procedure. Basal (preinfusion) levels of blood pressure, heart rate, PRA, and plasma NE were determined following a 60-minute equilibration period with slow intravenous infusion of 5% glucose in water in the supine position. These blood samples were collected between 9.00 and 11.00 a.m. An infusion of All (Hypertensin, Ciba-Geigy, Basel) or 1-NE was then started, and dose rates were titrated to reach two target levels of diastolic blood pressure (All-infusion) or mean blood pressure (NE-infusion), namely 10-15 ( Step I) and 15-25 mm Hg (Step II) above basal blood pressure.
19 2I Following 15 to 20 minutes of NE infusion at each of these rates, blood samples were obtained for measurement of plasma NE from the arm contralateral of the infusion. Blood pressure was recorded with the automatic recorder, Physiometrics SR 2. Each blood pressure was the mean of at least five measurements. The mean blood pressure was calculated as the sum of the diastolic and one-third of pulse pressure. The pressor doses of All and NE were calculated." The plasma norepinephrine clearance was calculated by the formula: 12 NE dose per time corresponding plasma NE -basal plasma NE Body mass index was calculated as weight/height 2 .
21
Apart from pressor response-testing (see above), blood pressure was measured using standard cuff and sphygmomanometer and the mean of three recordings was used. Appropriate cuff size relative to individual body habitus was used according to prior recommendations. 24 Exchangeable body sodium and blood volume were expressed by the ratio measured/expected for a normal individual with a given sex and body surface area, as reported previously from this laboratory. 20 Plasma or urinary sodium and potassium concentrations were determined by flame photometer, creatinine levels by autoanalyzer, PRA and plasma aldosterone by radioimmunoassay, 23 -26 catecholamines in urine with a fluorometric 27 and in plasma with a radioenzymatic method, 28 as used in this laboratory. 17 Since natural logarithmic transformation rather than absolute values followed a gaussian distribution, 16 " 21 the natural logarithmic transformation of PRA and plasma aldosterone, plasma NE, NE or All pressor doses were used for all statistical tests. For statistical comparison of some clinical and fluid-electrolyte parameters between our entire normal and hypertensive study population, an unpaired two-tailed Student / test was used. Subgroups with lean, overweight, or obese body size were derived from these populations. Statistical comparison of results among subgroups was performed by analysis of variance followed by test of Bonferroni. 29 Moreover, analysis of covariance was applied as indicated (see below).
Results
The results of all 99 normal subjects and 116 patients with essential hypertension are shown in table 1.
Age, body height, supine heart rate, blood volume, and exchangeable sodium were on average comparable between both study populations. Body weight was significantly higher in patients (p < 0.05) who also tended to have a higher urinary sodium. According to Thomas' body mass index (BMI), 23 
Considering the different size of these groups and the age-dependency of several factors analyzed in this study, we elected to restrict the further analysis to subgroups of similar size (n = 15) in normal-weight and overweight normal subjects which were matched for both BMI and age. Such subgroups could be derived for normal-weight, overweight, and obese patients with essential hypertension. A similar number of obese normal subjects were not available from the control population.
Mean values of the measured parameters in the two subgroups of normal subjects and the three patientsubgroups are summarized in tables 2 and 3. Mean age, body height, blood volume, exchangeable sodium, plasma or urinary sodium, potassium, and creatinine levels (table 2) as well as PRA, plasma aldoster- one and E, or urinary NE and E (table 2) , did not differ significantly among normal-weight or overweight normal subjects and patients with normal weight, overweight, or obesity. Supine and upright blood pressure were comparable between the two subgroups of normal subjects or between the three subgroups of patients (table 2) . Overweight patients tended to have an increased supine heart rate as compared to overweight normal subjects (p < 0.01). Supine and upright plasma NE tended to be slightly higher in overweight hypertensive than in normal-weight hypertensive patients, but were similar between normal-weight and obese hypertensive subgroups (table 3) .
Results of the pressor responsiveness studies are presented in table 4. Preinfusion plasma NE concentration, plasma NE levels during NE-infusion, and NEclearance during infusion were similar in normalweight and overweight normal subjects or patients. The NE pressor dose did also not differ significantly among the five subgroups, although it tended to be lower in normal-weight hypertensive patients than in normal-weight normal subjects. This pattern was unchanged by expressing the pressor dose in relation to body surface area. Preinfusion PRA and AH pressor effects did not differ among the five subgroups (table 4). Analysis of covariance using body weight or BMI as covariates confirmed the absence of significant differences in plasma and urinary sodium, potassium, or creatinine levels, supine and upright plasma renin activity, aldosterone, norepinephrine, or epinephrine concentrations as well as norepinephrine or angiotensin II pressor effects among the five studied subgroups. Only the difference in supine heart rate was again significant (F = 4.06).
Discussion
In the present study several important pressor factors or correlates such as blood volume, exchangeable sodium, plasma E, PRA or aldosterone levels, and urinary NE or E excretion rates did not differ among lean or overweight normal subjects and age-matched lean, overweight, or obese patients with mild-to-moderate essential hypertension. Differences in other study parameters among these subgroups appeared to be minimal. They included a slightly higher heart rate in overweight hypertensive than in overweight normal subjects, and a tendency for higher plasma NE levels in overweight than in normal-weight hypertensive subjects. These observations suggest that obesity, with or without hypertension, is usually not accompanied by extracellular sodium retention, hypervolemia, activation of the renin-angiotensin-aldosterone system, or distinct increase in adrenergic activity. Cardiovascular responsiveness to All was also similar in normal and hypertensive subjects of various body sizes. On the other hand, a tendency for exaggerated NE pressor responsiveness relative to plasma NE, which was previously described in larger unselected groups with essential hypertension,'
6 -x was noted in the subgroup of lean hypertensive patients but not in the overweight or obesity subgroups. This is consistent with a possible pathogenetic difference between certain hypertensive patients with or without associated obesity.
There is still no agreement on a causal interrelationship between dietary salt consumption and hypertension. 31 "" It has been suggested by some and denied by others that sodium intake may represent a possible link relating high blood pressure and obesity.
3 - 4 We could not study an appropriately sized control group of obese normal subjects, but urinary excretion of sodium increased in parallel with body weight in both our normal and hypertensive subjects. The potent antihypertensive influence of weight reduction without concomitant salt restriction 4 -3 points to a sodium-independent connection between hypertension and obesity per se. This notion does not militate against a modulatory effect of sodium intake on the blood pressure of certain susceptible persons with or without obesity. 31 - 32 Some reports of hypervolemia in obesity were based on the amount of total blood volume. 8 -9 Since total blood volume correlates positively with body weight, 20 the latter is inappropriate as a frame of reference for comparison between subjects of different body weight. Dependency of total blood volume or exchangeable sodium on body habitus is not eliminated by correction for either weight or height only. However, satisfactory correction is achieved by relating these body constituents to body surface area which, therefore, is presently considered as the most appropriate frame of reference (at the Meeting of the International Society of Hypertension Committee for Standardization of Blood Volume and Cardiac Output, Milan, May 30, 1981) . The finding of a normal relationship between circulatory volume or exchangeable sodium and body surface area in our overweight normal or hypertensive subjects is in accord with, and complements a previous observation of, unaltered blood volume and cardiac output relative to body surface area."
A disturbed sodium transport across erythrocyte cell membrane with an increased intracellular sodium concentration was recently described in obesity 34 as well as in essential hypertension. 33 x Whether a similar disturbance may also affect vascular muscle cells is presently unknown. Nevertheless, it has been speculated that increased intracellular sodium and, as its consequence, a rise in intracellular calcium could enhance vascular tone. 37 The demonstration of exaggerated NEpressor responsiveness relative to plasma-NE in borderline and established essential hypertension 15 -30 -38 may be consistent with altered cellular cation metabolism, although several other mechanisms appear equally possible. 15 On the other hand, the absence of a distinct disturbance in the relationship between NE or angiotensin pressor responses and endogenous plasma NE or PRA levels in our overweight or obese subjects with or without hypertension is an argument against an increase in basal vascular tone related to obesity per se.
The generally normal plasma catecholamine or renin levels in the present or previously studied overweight subjects with or without hypertension do not militate against a contribution of a reduced sympathetic 11 and/or renin activity 5 to the antihypertensive mechanism of fasting. Inhibition of any one of the various blood pressure control factors may result in an antihypertensive effect, regardless of whether the basal activity of this factor is normal or increased.
